Health care stocks rose late Friday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.
The iShares Biotechnology ETF (IBB) was 0.9% higher.
In corporate news, BioXcel Therapeutics (BTAI) shares jumped 24% after the company regained compliance with Nasdaq's minimum closing bid price rule.
Owens & Minor (OMI) shares surged 40% after it reported better-than-expected quarterly results and a share buyback plan Friday.
DocGo (DCGO) shares fell past 21% after the company reported a Q4 net loss, surprising analysts who expected a profit.
Praxis Precision Medicines (PRAX) shares dropped 41%. An independent data monitoring committee overseeing the company's study 1 of the Essential3 program of ulixacaltamide in essential tremor recommended that the study be "stopped for futility."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.